Regulatory Briefs: FDA Device Reclassifications, Meetings Announcements
This article was originally published in The Gray Sheet
FDA proposes class II for nonthermal shortwave therapy devices and updates regulations to reflect class II designation for neuropsychiatric assessment device. Meetings on manufacturing quality, clinical trials and medical countermeasures announced. More regulatory news.